Literature DB >> 12424702

Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury.

W Michael Scheld1, Uwe Koedel, Barnett Nathan, Hans-Walter Pfister.   

Abstract

No bacterial disease has undergone a more dramatic change in epidemiology during the past decade than acute bacterial meningitis. This review describes the changing epidemiology and considers some important recent observations that contribute to our understanding of the pathogenesis and pathophysiology of meningitis. The major focus is on the mechanisms of neuronal injury and the pathophysiologic concepts responsible for death and neurologic sequelae. In recent years, experimental studies have amplified our understanding of the substantial body of evidence that now implicates cytokines and chemokines, proteolytic enzymes, and oxidants in the inflammatory cascade leading to tissue destruction in bacterial meningitis. The molecular mechanisms responsible for oxidant-induced neuronal injury in meningitis are explored in some depth. Genetic targeting and/or pharmacologic blockade of the implicated pathways may be a future strategy for therapeutic adjunctive measures to improve outcome and may hold substantial promise, in concert with antimicrobial agents, in humans with acute bacterial meningitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424702     DOI: 10.1086/344939

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  88 in total

Review 1.  Bacterial meningitis: diagnosis and treatment.

Authors:  Russell D Snyder
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

Review 2.  Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice.

Authors:  Robert Paul; Uwe Koedel; Hans-Walter Pfister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 3.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 4.  Chemotactic factors in cerebrospinal fluid during bacterial meningitis.

Authors:  Petra J G Zwijnenburg; Tom van der Poll; John J Roord; A Marceline van Furth
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 5.  Concepts and mechanisms: crossing host barriers.

Authors:  Kelly S Doran; Anirban Banerjee; Olivier Disson; Marc Lecuit
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

6.  Association between Experimental Bacterial Meningitis and Periapical Lesion.

Authors:  Tatiana Barichello; Soraia Netto; Renan Antonio Ceretta; Jaqueline S Generoso; Lutiana R Simões; Patrícia Ávila Ribeiro; Josiane Budni; João Quevedo
Journal:  J Clin Diagn Res       Date:  2015-05-01

7.  Systemic inflammation alters the inflammatory response in experimental lipopolysaccharide-induced meningitis.

Authors:  T O'Reilly; C Ostergaard; J Vaxelaire; O Zak
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

8.  Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response.

Authors:  Jagath L Kadurugamuwa; Kshitij Modi; Olivier Coquoz; Brad Rice; Steven Smith; Pamela R Contag; Tony Purchio
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

9.  Circulating levels of vasoactive peptides in patients with acute bacterial meningitis.

Authors:  Ronan M G Berg; Gitte Irene Strauss; Flemming Tofteng; Tavs Qvist; Lars Edvinsson; Jan Fahrenkrug; Jesper Qvist; Lise Fonsmark; Peter Skinhøj; Kirsten Møller
Journal:  Intensive Care Med       Date:  2009-06-10       Impact factor: 17.440

10.  Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.

Authors:  Yue Wang; Hongfei Zhao; Chuangxin Lin; Jie Ren; Shizhong Zhang
Journal:  Neurochem Res       Date:  2015-10-26       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.